These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6212074)

  • 1. Estimation of biliary excretion of ureidopenicillins in healthy volunteers using marker dilution technique.
    Gundert-Remy U; Frohnapfel F; Jourdan W; Weber E; Stiehl A
    Br J Clin Pharmacol; 1982 Jun; 13(6):795-801. PubMed ID: 6212074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary excretion of mezlocillin in patients with hepatic disease.
    Hildebrandt R; Gundert-Remy U; Raedsch R; Sieg A; Stiehl A
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):384-7. PubMed ID: 7582392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative biliary excretion of mezlocillin and 12 other beta-lactam antibiotics (author's transl)].
    Comte F; Brogard JM; Kopferschmitt J; Dorner M; Lavillaureix J
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):353-60. PubMed ID: 6460975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental and clinical study of the biliary elimination of mezlocillin (author's transl)].
    Brogard JM; Kopferschmitt J; Dorner M; Lavillaureix J
    Pathol Biol (Paris); 1981 Sep; 29(7):405-10. PubMed ID: 6457274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of azlocillin in patients with biliary t-tube drainage.
    Gundert-Remy U; Weber E
    Eur J Clin Pharmacol; 1982; 22(5):435-9. PubMed ID: 7117356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary elimination of mezlocillin: an experimental and clinical study.
    Brogard JM; Kopferschmitt J; Arnaud JP; Dorner M; La Villaureix J
    Antimicrob Agents Chemother; 1980 Jul; 18(1):69-76. PubMed ID: 6448023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin.
    Bergan T; Thorsteinsson SB; Steingrimsson O
    Chemotherapy; 1982; 28(3):160-70. PubMed ID: 6212204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excretion of azlocillin and mezlocillin by the normal pancreas and in acute pancreatitis in dogs and rats.
    Demol P; Singer MV; Bernemann D; Linzenmeier G; Goebell H
    Digestion; 1983; 27(2):93-9. PubMed ID: 6628842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biliary excretion of mezlocillin].
    Rösch W; Stock KP; Burkhardt F
    Fortschr Med; 1981 Jan; 99(3):76-8. PubMed ID: 6451569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Degradation of Azlocillin and Mezlocillin / I. Behaviour in biological material and buffer (author's transl)].
    Gundert-Remy U; Weber E
    Arzneimittelforschung; 1981; 31(12):2041-4. PubMed ID: 6460506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of mezlocillin in patients with biliary t-tube drainage.
    Gundert-Remy U; Förster D; Schacht P; Weber E
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():65-75. PubMed ID: 6210684
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantification of temocillin biliary excretion and gallbladder bile concentration in healthy subjects.
    Maudgal DP; Lanzini A; Northfield TC; Bridges C; Joseph AE
    Drugs; 1985; 29 Suppl 5():146-50. PubMed ID: 4029019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biliary excretion and pharmacokinetics of mezlocillin in jaundiced patients with external bile drainage.
    Dooley JS; Gooding A; Hamilton-Miller JM; Brumfitt W; Sherlock S
    Liver; 1983 Aug; 3(4):201-6. PubMed ID: 6672502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic studies on the penetration of azlocillin and mezlocillin into bone and tissue fluid (author's transl)].
    Wittmann DH; Schassan HH; Seidel H
    Arzneimittelforschung; 1981; 31(7):1157-62. PubMed ID: 6456009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of acylureidopenicillin pharmacokinetics.
    Bergan T
    Scand J Infect Dis Suppl; 1981; 29():33-48. PubMed ID: 7031864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E; Remien J; Richter E; Frank U; Adam D
    Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo action of mezlocillin and azlocillin combined with sisomicin.
    Dzierzanowska D; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):346-55. PubMed ID: 6417945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved procedure for the determination of the ureidopenicillins azlocillin and mezlocillin plasma by high-performance liquid chromatography.
    Hildebrandt R; Gundert-Remy U
    J Chromatogr; 1982 Mar; 228():409-12. PubMed ID: 6210704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.